DE69312176T2 - Verfahren zur Herstellung von mit Alpha-Anomeren angereichterten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl Sulfonaten - Google Patents

Verfahren zur Herstellung von mit Alpha-Anomeren angereichterten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl Sulfonaten

Info

Publication number
DE69312176T2
DE69312176T2 DE69312176T DE69312176T DE69312176T2 DE 69312176 T2 DE69312176 T2 DE 69312176T2 DE 69312176 T DE69312176 T DE 69312176T DE 69312176 T DE69312176 T DE 69312176T DE 69312176 T2 DE69312176 T2 DE 69312176T2
Authority
DE
Germany
Prior art keywords
anomer
sulfonate
acid
deoxy
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69312176T
Other languages
German (de)
English (en)
Other versions
DE69312176D1 (de
Inventor
Ta-Sen Indianapolis Indiana 46236 Chou
Charles David Indianapolis Indiana 46227 Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69312176D1 publication Critical patent/DE69312176D1/de
Application granted granted Critical
Publication of DE69312176T2 publication Critical patent/DE69312176T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69312176T 1992-06-22 1993-06-21 Verfahren zur Herstellung von mit Alpha-Anomeren angereichterten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl Sulfonaten Expired - Lifetime DE69312176T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/902,305 US5256798A (en) 1992-06-22 1992-06-22 Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates

Publications (2)

Publication Number Publication Date
DE69312176D1 DE69312176D1 (de) 1997-08-21
DE69312176T2 true DE69312176T2 (de) 1997-12-11

Family

ID=25415655

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312176T Expired - Lifetime DE69312176T2 (de) 1992-06-22 1993-06-21 Verfahren zur Herstellung von mit Alpha-Anomeren angereichterten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl Sulfonaten

Country Status (14)

Country Link
US (1) US5256798A (enExample)
EP (1) EP0577302B1 (enExample)
JP (1) JP3379993B2 (enExample)
AT (1) ATE155476T1 (enExample)
BR (1) BR9302429A (enExample)
CA (1) CA2098882C (enExample)
DE (1) DE69312176T2 (enExample)
DK (1) DK0577302T3 (enExample)
ES (1) ES2105114T3 (enExample)
GR (1) GR3024975T3 (enExample)
HU (1) HU216832B (enExample)
IL (1) IL106077A (enExample)
MX (1) MX9303712A (enExample)
TW (1) TW224101B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69311000T2 (de) * 1992-06-22 1997-11-27 Lilly Co Eli Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
US5424416A (en) * 1993-08-25 1995-06-13 Eli Lilly And Company Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
SG158136A1 (en) * 2004-09-14 2010-01-29 Pharmasset Inc Preparation of 2`-fluoro-2`- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
CA2598895A1 (en) * 2005-03-04 2006-09-08 Dabur Pharma Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides
BRPI0610950A2 (pt) * 2005-06-03 2010-08-03 Scinopharm Taiwan Ltd processo para produção de um sulfonato de 2-deoxi-2, 2-difluoro-d-ribofuranosil enriquecido de alfa anÈmero, e uso do mesmo para produção de um beta nocleosìdeo
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
AT502221A1 (de) * 2005-07-20 2007-02-15 Pharmacon Forschung & Beratung Gmbh Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
WO2007092705A2 (en) * 2006-02-07 2007-08-16 Chemagis Ltd. Process for preparing gemcitabine and associated intermediates
US20070249823A1 (en) * 2006-04-20 2007-10-25 Chemagis Ltd. Process for preparing gemcitabine and associated intermediates
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
CN101024667B (zh) * 2007-03-30 2011-01-26 湖北益泰药业有限公司 盐酸吉西他宾的合成方法
US20080262215A1 (en) * 2007-04-23 2008-10-23 Chemagis Ltd. Gemcitabine production process
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
BRPI0923815A2 (pt) * 2008-12-23 2015-07-14 Pharmasset Inc Síntese de nucleosídeos de purina
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
SI3290428T1 (sl) 2010-03-31 2022-01-31 Gilead Pharmasset Llc Tableta, ki obsega kristalinični (S)-izopropil 2-(((S)-(((2R,3R,4R,5R) -5-(2,4-diokso-3,4-dihidropirimidin-1(2H)-il)-4-fluoro-3-hidroksi-4- metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
WO2015030853A1 (en) 2013-08-27 2015-03-05 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
CN103692332B (zh) * 2013-12-31 2015-12-09 景宁畲族自治县通用机械配件厂(普通合伙) 全自动抛光除油机
CN107793334A (zh) * 2017-09-27 2018-03-13 九江善水科技股份有限公司 芳基磺酸铵盐化合物、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3856158T2 (de) * 1987-08-28 1998-08-20 Lilly Co Eli Verfahren zur Herstellung von Zwischenverbindungen verwendbar in der Herstellung von 2',2'-Difluoronucleosiden
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides

Also Published As

Publication number Publication date
DE69312176D1 (de) 1997-08-21
HU216832B (hu) 1999-09-28
HUT65207A (en) 1994-05-02
JP3379993B2 (ja) 2003-02-24
CA2098882A1 (en) 1993-12-23
ATE155476T1 (de) 1997-08-15
IL106077A0 (en) 1993-10-20
MX9303712A (es) 1994-05-31
TW224101B (enExample) 1994-05-21
ES2105114T3 (es) 1997-10-16
DK0577302T3 (da) 1997-10-06
CA2098882C (en) 2004-05-04
US5256798A (en) 1993-10-26
EP0577302A1 (en) 1994-01-05
EP0577302B1 (en) 1997-07-16
JPH0656865A (ja) 1994-03-01
BR9302429A (pt) 1994-01-11
IL106077A (en) 1998-07-15
GR3024975T3 (en) 1998-01-30
HU9301825D0 (en) 1993-09-28

Similar Documents

Publication Publication Date Title
DE69312176T2 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereichterten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl Sulfonaten
DE69314239T2 (de) Verfahren zur Stereoselektivglycosylierung
DE69315752T2 (de) Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten
DE69311000T2 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
DE69621180T2 (de) 2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-Nukleosiden
DE69308400T2 (de) Verfahren zur Stereoselektivanionglycosylierung
DE69108014T2 (de) Verfahren zur herstellung von nucleosiden und ihre analogen.
DE3856330T2 (de) Verfahren zur selektiven Isolierung von beta-2'-desoxy-2'2'-difluorocytidin oder seiner Salze
DE2555479A1 (de) Verfahren zur herstellung von 3', 4'-alpha-epoxyneamin und verwandten aminoglykosidischen antibiotika sowie die so hergestellten verbindungen
CH500203A (de) Verfahren zur Herstellung von Nucleosiden
DE69602834T2 (de) Verfahren zur herstellung von anthracyclin antibiotica
DE69222643T2 (de) Verfahren zur herstellung von demethylepypodophyllotoxin
DE69206893T2 (de) Nucleosidderivate und deren Herstellung
DE69401045T2 (de) Stereoselektives Verfahren zur Herstellung von Beta-Anomer angereicherten 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy-geschützten 1-alkyl und aryl-sulfonat-Zwischenprodukten
DE68920648T2 (de) Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin.
DE69019052T2 (de) Verfahren zur Herstellung von 2'Deoxy-5-trifluoromethyl-ss-uridin.
DE68915067T2 (de) Verfahren zur Herstellung von 2'-Deoxy-beta-adenosin.
DE69323352T2 (de) Verfahren zur Herstellung von mit Beta-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Aryl-Sulfonaten
Yamasaki et al. Syntheses of 2-Amino-2, 3-dideoxy-l-and-d-Ribohexose by Utilizing an O→ N Acetyl Migration
DE69719673T2 (de) D-pentofuranose-derivate und verfahren zu ihrer herstellung
DE69808457T2 (de) Verfahren zur herstellung von deoxyuridinderivate
DE69602983T2 (de) Darstellung von D4T aus 5-Methyluridin
DE69421665T2 (de) Anomere Fluorribosylamine
AT400953B (de) Pentofuranosid-derivate, deren herstellung und verwendung
DE68921673T2 (de) 3-Deoxymycaminosyltylonolidderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN